Blog
RSS FeedPosted by Michael Wonder on 09 Dec 2019
Cancer costs can be unbearable - a special Centrelink payment is needed, couple say
9 December 2019 - A Swansea couple has called for a special Centrelink payment for people and their carers living ...
Posted by Michael Wonder on 09 Dec 2019
SMC - December 2019 decisions
9 December 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 09 Dec 2019
Prescription drug prices down slightly last year
5 December 2019 - A government report says prices for prescription drugs edged down 1% last year, driven by declines for ...
Posted by Michael Wonder on 09 Dec 2019
Medicare costs for seniors lowered in Senate drug price bill
7 December 2019 - Seniors would pay a smaller portion of their drugs’ cost and be shielded from huge one-time ...
Posted by Michael Wonder on 09 Dec 2019
ICER issues final report and policy recommendations for add-on therapies to treat type 2 diabetes
9 December 2019 - Oral GLP-1 semaglutide achieves commonly cited thresholds for cost-effectiveness but is less cost-effective than SGLT-2 competitor empagliflozin. ...
Posted by Michael Wonder on 09 Dec 2019
Galderma investigational therapy nemolizumab granted FDA breakthrough therapy designation for the treatment of patients suffering from prurigo nodularis
9 December 2019 - Galderma today announced that the U.S. FDA has granted breakthrough therapy Designation to the investigational therapy ...
Posted by Michael Wonder on 09 Dec 2019
Sesen Bio initiates rolling submission of BLA for Vicinium to FDA
9 December 2019 - --Sesen Bio today announced that on 6 December 2019, the Company initiated the submission of its biologics ...
Posted by Michael Wonder on 09 Dec 2019
FDA approving drugs at breakneck speed, raising alarm
7 December 2019 - Breakthrough products beating deadlines by weeks, even months. ...
Posted by Michael Wonder on 09 Dec 2019
Court rules against FDA’s finding that a device was a drug
9 December 2019 - Whether the US FDA classifies a product as a drug or a device can have huge ...
Posted by Michael Wonder on 09 Dec 2019
China to strengthen medicine price monitoring
9 December 2019 - China's National Healthcare Security Administration has issued a guideline to strengthen regular supervision on medicine prices. ...
Posted by Michael Wonder on 09 Dec 2019
EMA publishes agenda for 9-12 December CHMP meeting
9 December 2019 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 09 Dec 2019
Complaints about private health insurance rule changes jump
9 December 2019 - Complaints about private health insurance rule changes doubled in the September quarter, coinciding with "upheaval" in ...
Posted by Michael Wonder on 09 Dec 2019
Proposals for funding in the blood, alimentary and immunosuppressant therapy areas
9 December 2019 - PHARMAC is seeking feedback on proposals to widen funded access to medicines in the blood, alimentary ...
Posted by Michael Wonder on 09 Dec 2019
Base drug prices on value rather than R&D
8 December 2019 - For decades, R&D spending on pharmaceuticals has gone up more or less in tandem with the ...
Posted by Michael Wonder on 09 Dec 2019
Health funds call for urgent reform after government caps price hikes
9 December 2019 - Health funds strong-armed by the government into rising their membership fees by the lowest annual rate ...
Posted by Michael Wonder on 09 Dec 2019
Medibank warns of health insurance crisis
9 December 2019 - One of the nation’s biggest health insurers has appealed for governments and healthcare providers to work ...